DiaTex, Inc.

Patent Applications and Registrations

Patent applications and USPTO patent grants for DiaTex, Inc..The latest application filed is for "cb-0406 choline salt".

Company Profile

0.17.9

DiaTex, Inc. - San Antonio TX US
DiaTex, Inc. - N/A
Diatex, Inc. - Metabolex, Inc.

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
CB-0406 choline salt App 20210355066 - Boerrigter; Stephan X.M. ; et al.	2021-11-18
CB-0406 tromethamine salt App 20210355065 - Boerrigter; Stephan X.M. ; et al.	2021-11-18
Methods for treating hyperuricemia in patients with gout using halofenate or halofenic acid and a second urate-lowering agent Grant 10,137,112 - Roberts , et al. November 27, 2	2018-11-27
Methods for treating hyperuricemia in patients with gout using halofenate or halofenic acid and a second urate-lowering agent App 20180214420 - Roberts; Brian K. ; et al.	2018-08-02
Crystalline solid and amorphous forms of (-)-halofenate and methods related thereto Grant 9,845,285 - Daugs , et al. December 19, 2	2017-12-19
Methods for treating hyperuricemia in patients with gout using halofenate or halofenic acid and a second urate-lowering agent Grant 9,801,860 - Roberts , et al. October 31, 2	2017-10-31
Crystalline Solid and Amorphous Forms of (-)-Halofenate and Methods Related Thereto App 20160280636 - Daugs; Edward D. ; et al.	2016-09-29
Methods for treating hyperuricemia in patients with gout using halofenate or halofenic acid and a second urate-lowering agent Grant 9,439,891 - Roberts , et al. September 13, 2	2016-09-13
Methods for treating hyperuricemia in patients with gout using halofenate or halofenic acid and a second urate-lowering agent Grant 9,433,612 - Roberts , et al. September 6, 2	2016-09-06
Crystalline solid and amorphous forms of (-)-halofenate and methods related thereto Grant 9,233,914 - Daugs , et al. January 12, 2	2016-01-12
Crystalline Solid and Amorphous Forms of (-)-Halofenate and Methods Related Thereto App 20150225333 - Daugs; Edward D. ; et al.	2015-08-13
Crystalline solid and amorphous forms of (-)-halofenate and methods related thereto Grant 8,993,797 - Daugs , et al. March 31, 2	2015-03-31
Crystalline Solid and Amorphous Forms of (-)-Halofenate and Methods Related Thereto App 20140024852 - Daugs; Edward D. ; et al.	2014-01-23
Crystalline solid and amorphous forms of (-)-halofenate and methods related thereto Grant 8,507,719 - Daugs , et al. August 13, 2	2013-08-13
Crystalline Solid and Amorphous Forms of (-)-Halofenate and Methods Related Thereto App 20120232303 - Daugs; Edward D. ; et al.	2012-09-13
Use of (-) (3-Trihalomethylphenoxy) (4-Halophenyl) Acetic Acid Derivatives for Treatment of Insulin Resistance, Type 2 Diabetes, Hyperlipidemia and Hyperuricemia App 20120225940 - Luskey; Kenneth L. ; et al.	2012-09-06
Crystalline solid and amorphous forms of (-)- halofenate and methods related thereto Grant 8,203,019 - Daugs , et al. June 19, 2	2012-06-19
Use of (-) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes, hyperlipidemia and hyperuricemia Grant 7,576,131 - Luskey , et al. August 18, 2	2009-08-18
Use of (-) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes and hyperlipidemia Grant 6,646,004 - Luskey , et al. November 11, 2	2003-11-11
Use of (-) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes, hyperlipidemia and hyperuricemia Grant 6,624,194 - Luskey , et al. September 23, 2	2003-09-23
Use of (-) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes, hyperlipidemia and hyperuricemia Grant 6,613,802 - Luskey , et al. September 2, 2	2003-09-02

Company Registrations

NCAGE Code	0ECN0	DIATEX INC
NCAGE Code	4SM02	DIATEX INC
CAGE Code	0ECN0	DIATEX INC
CAGE Code	4SM02	DIATEX INC

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.